Jenn Michelle Pedini, executive director of the marijuana reform group Virginia NORML, said she wasn’t surprised that the board opted for a closed process. She said other states that have gone through similar processes to establish medical marijuana programs have disclosed documents at the end of the process.
Regardless of how the legalities play out, Pedini said, Virginia patients have a right to know if they’re getting the best option available.
“It is in the best interests of patients, of consumers, for there to be transparency throughout this process,” Pedini said. “Patients deserve to know who is making their medicine, if that company has been operational in other states, if they have been compliant, if they have had to stop production or have been cited for other issues.”